History of public health crises in Japan

Journal of Public Health Policy

Volumn 28, Issue 2, 2007, Pages 221-237

  Imamura, Tomoaki ^b   Ide, Hiroo ^a   Yasunaga, Hideo ^b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b NONE

Author keywords

Environmental pollution; Food borne diseases; Health hazards due to pharmaceuticals; Public health policy

Indexed keywords

DRUG; ORGANOARSENIC DERIVATIVE; POLYCHLORINATED BIPHENYL; THALIDOMIDE;

ARSENIC POISONING; BUSINESS ETHICS; ETHICS; HEALTH CARE POLICY; HISTORY; HUMAN; INDUSTRY; JAPAN; POLLUTION; PUBLIC HEALTH; REVIEW; STAPHYLOCOCCUS;

ARSENIC POISONING; ARSENICALS; ENVIRONMENTAL POLLUTION; ETHICS, BUSINESS; HEALTH POLICY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INDUSTRY; JAPAN; PHARMACEUTICAL PREPARATIONS; POLYCHLORINATED BIPHENYLS; PUBLIC HEALTH; STAPHYLOCOCCUS; THALIDOMIDE;

EID: 34250886893     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/palgrave.jphp.3200131     Document Type: Review

References (62)

1. Nomiyama K. Recent progress and perspectives in cadmium health effects studies. Sci Total Environ. 1980;14:199-232.
2. Tsuchiya K. Health effects of cadmium with special reference to studies in Japan. IARC Sci Publ. 1992;118:35-49.
3. Nogawa K, Kido T. Biological monitoring of cadmium exposure in Itai-itai disease epidemiology. Int Arch Occup Environ Health. 1993;65(1 Suppl):S43-6.
4. Kazantzis G. Cadmium, osteoporosis and calcium metabolism. BioMetals. 2004;17:493-8.
5. Ogino N, Yoshioka K. Itai-itai byou no gen-in ni kansuru kenkyu ni tsuite [A study on the etiology of Itai-itai disease]. Nippon Seikeigekagakkai zasshi [J Jpn Orthop Assoc]. 1961;35:812-5 (in Japanese).
6. McAlpine D, Araki S. Minamata disease: an unusual neurological disorder caused by contaminated fish. Lancet. 1958;2:629-31.
7. Igata A. Epidemiological and clinical features of Minamata disease. Environ Res. 1993;63:157-69.
8. Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol. 1995;25:1-24.
9. Eto K. Pathology of Minamata disease. Toxicol Pathol. 1997;25:614-23.
10. Eto K. Minamata disease. Neuropathology. 2000;20(Suppl):S14-9.
11. Yoshida K, Oshima H, Imai M. Air pollution and asthma in Yokkaichi. Arch Environ Health. 1966513:763-8.
12. Yoshida K, Takatsuka Y, Kitabatake M, Oshima H, Imai M. Air pollution and its health effects in Yokkaichi area. Review on Yokkaichi asthma. Mie Med J. 1969;18:195-209.
13. Kitagawa T. Cause analysis of the Yokkaichi asthma episode in Japan. J Air Pollut Control Assoc. 1984;34:743-6.
14. Imai M, Yoshida K, Kitabatake M. Mortality from asthma and chronic bronchitis associated with changes in sulfur oxides air pollution. Arch Environ Health. 1986;41:29-35.
15. Yamashita N, Doi M. Some consideration about registration of sufferers from poisoning by arsenic tainted Morinaga Dry Milk. Nippon Eiseigaku Zasshi [JpnJ Hygiene]. 1975;19:568-80 (in Japanese).
16. Yamashita N, Doi M, Nishio M, Hojo H, Tanaka M. Recent observations of Kyoto children poisoned by arsenic tainted "Morinaga Dry Milk". Nippon Eiseigaku Zasshi [Jpn J Hygiene]. 1972;27:364-99 (in Japanese).
17. Yoshimura T. Yusho in Japan. Indust Health. 2003;41:139-48.
18. Kashimoto T, Miyata H, Kunita S, Tung TC, Hsu ST, Chang KJ, et al. Role of polychlorinated dibenzofuran in Yusho (PCB poisoning). Arch Environ Health. 1981;36:321-6.
19. Masuda Y, Yoshimura H. Chemical analysis and toxicity of polychlorinated biphenyls and dibenzofurans in relation to Yusho. J Toxicol Sci. 1982;7:161-75.
20. Masuda Y, Yoshimura H. Polychlorinated biphenyls and dibenzofurans in patients with Yusho and their toxicological significance: a review. Am J Indust Med. 1984;5:31-44.
21. Kuratsune M, Morikawa Y, Hirohata T, Nishizumi M, Seishi K, Yoshimura T, et al. An epidemiologic study on "Yusho" or chlorobiphenyls poisoning. Fukuoka Acta Medica. 1969;60:513-32.
22. Kuratsune M, Yoshimura T, Matsuzaka J, Yamaguchi A. Epidemiologic study of polychlorinated biphenyls. Environ Health Perspect. 1972;1:119-28.
23. Nakayama J, Matsuda Y, Kuratsune M. Determination of polychrorinated dibenzofurans in tissues of patients with Yusho. Fd Cosmet Toxicol. 1977;15:195-8.
24. Matsuda Y, Kagawa R, Kuroki H. Transfer of polychlorinated biphenyls from mothers to fetuses and infants. Fd Cosmet Toxicol. 1978;16:543-6.
25. Yukioka H, Kurita S. Escherichia coli 0157 infection disaster in Japan, 1996. Eur J Emerg Med. 1997;4:165.
26. Takeda Y. Enterohaemorrhagic Escherichia coli. World Health Stat Q. 1997;50:74-80.
27. Mermin JH, Griffin PM. Public health in crisis: outbreaks of Escherichia coli 0157:H7 infections in Japan. Am J Epidemiol. 1999;150:797-803.
28. Michino H, Araki K, Minami S, Takaya S, Sakai N, Miyazaki M, et al. Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol. 1999;150:787-96.
29. Swinbanks D. Japan shuns radishes after 'possible link' to E. coli. Nature. 1996;382:567.
30. Asao T, Kumeda Y, Kawai T, Shibata T, Oda H, Haruki K, et al. An extensive outbreak of staphylococcal food poisoning due to low-fat milk in Japan: estimation of enterotoxin A in the incriminated milk and powdered skim milk. Epidemiol Infect. 2003;130:33-40.
31. Yamashita K, Kanazawa Y, Ueno M, Ohta H, Kitaguchi M, Kawakami T, et al. Significance of the detection of staphylococcal enterotoxin A gene in low fat milk which caused a serious outbreak of food poisoning. J Food Hyg Soc Jpn. 2003;544:186-90 (in Japanese).
32. Yamane H. Outbreak of the food poisoning due to contaminated low fat milk in Japan and the preventive measures. J Food Hyg Soc Jpn. 2003;44:J281-5 (in Japanese).
33. Ikeda T, Tamate N, Yamaguchi K, Makino S. Mass outbreak of food poisoning disease caused by small amounts of staphylococcal enterotoxins A and H. Appl Environ Microbiol. 2005;71:2793-5.
34. Mellin GW, Katzenstein M. The saga of thalidomide: neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med. 1962;267:1184-92.
35. Kelsey FO. Thalidomide update: regulatory aspects. Teratology. 1988;38:221-6.
36. Lenz W. A short history of thalidomide embryopathy. Teratology. 1988;38:203-15.
37. Kajii T, Shinohara M. Thalidomide in Japan. Lancet. 1963;281:501-2.
38. Kajii T. Thalidomide experience in Japan. Ann Paediatr [Int Rev Pediatr]. 19655205:341-54.
39. Kajii T, Kida M, Takahashi K. The effect of thalidomide intake during 113 human pregnancies. Teratology. 1973;8:163-6.
40. Miyairi M, Imura O, Tamura T, Hoshikawa K, Chida A. A case of so-called "subacute-myelo-optico-neuropathy" (SMON) from which Coxsackie type A 4 was isolated. Nippon Naika Gakkai Zasshi [J Jpn Soc Int Med]. 1968;57:1113-7.
41. Ota Z. Electron microscopic demonstration of a new virus isolated from a patient with SMON. Acta Med Okayama. 1970;24:573-7.
42. Inoue YK, Nishibe Y, Nakamura Y. Virus associated with S.M.O.N. in Japan. Lancet. 1971;297:853-4.
43. Tsubaki T, Honma Y, Hoshi M. Neurological syndrome associated with clioquinol. Lancet. 1971;297:696-7.
44. Nakae K, Yamamoto S, Igata A. Subacute myelo-optico-neuropathy (S.M.O.N.) in Japan. A community survey. Lancet. 1971;297:510-2.
45. Cavanagh JB. The aetiology of S.M.O.N. Lancet. 1971;297:868-9.
46. Nakae K, Yamamoto S, Shigematsu I, Kono R. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey. Lancet. 1973;301:171-3.
47. Barker S, Swinbanks D. Health ministry accepts liability in Japanese HIV-infected blood row. Nature. 1996;379:663-4.
48. Swinbanks D. Documents confirm delays in Japanese HIV blood scandal. Nature. 1996;379:760.
49. Barker S. Courts back research and compensation for Japanese HIV victims. Nature. 1996;380:92.
50. Spurgeon D. Japan agrees to pay HIV-blood victims. Nature. 1996;380:278.
51. Swinbanks D. Japan's HIV blood scandal broadens out. Nature. 1996;383:191.
52. Guest R. Japan apologizes for HIV infected blood products. BMJ. 1996;312:461.
53. Nathan R. Guilty pleas intensify row over contaminated blood. Nat Med. 1997;3:480-1.
54. Saegusa A. Japanese officials were aware of HIV in blood products. Nat Med. 1998;4:991.
55. Watts J. Tainted-blood revelation shocks Japanese. Lancet. 1998;352:554.
56. Cullinane J. Tainted blood and vengeful spirits: the legacy of Japan's Yakugai-AIDS trial. Culture, Med Psychiatry. 2005;29:5-31.
57. Seki Y, Yamazaki Y, Inoue Y, Wakabayashi C, Seto S. How HIV infected hemophiliacs in Japan were informed of their HIV-positive status. AIDS Care. 2002;14:651-64.
58. Egilman D, Scout. Corporate corruption of science-the case of chromium(VI). Int J Occup Environ Health. 2006;12:169-76.
59. Bradley CA, Rolka H, Walker D, Loonsk J. BioSense: implementation of a National Early Event Detection and Situational Awareness System. MMWR - Morb Mortal Wkly Rep. 2005;54(Suppl):11-9.
60. Reyes M, Gary Jr HE, Dobbins JG, Randall B, Steele L, Fukuda K, et al. Surveillance for chronic fatigue syndrome - four US cities, September 1989 through August 1993. MMWR - Morb Mortal Wkly Rep. 1997;46:1-13.
61. Fischer H, Konig P, Dierich MP, Allerberger F. Hemolytic-uremic syndrome surveillance to monitor trends in infection with Escherichia coli 0157 and non-O157 enterohemorrhagic E. coli in Austria. Pediatr Infect Dis J. 2001;20:316-8.
62. Miller B, Kassenborg H, Dunsmuir W, Griffith J, Hadidi M, Nordin JD, et al. Syndromic surveillance for influenzalike illness in ambulatory care network. Emerg Infect Dis. 2004;10:1806-11.